KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Preferred Shares (2017 - 2018)

Biolife Solutions (BLFS) has disclosed Preferred Shares for 2 consecutive years, with $3.0 as the latest value for Q3 2018.

Quarterly Preferred Shares fell 25.0% to $3.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $3.0 through Sep 2018, down 25.0% year-over-year, with the annual reading at $4.0 for FY2017, N/A changed from the prior year.
Preferred Shares for Q3 2018 was $3.0 at Biolife Solutions, roughly flat from $3.0 in the prior quarter.
The five-year high for Preferred Shares was $4.0 in Q2 2017, with the low at $3.0 in Q2 2018.